U.S., Nov. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07236437) titled 'Living Well Program: Impact on Healthcare Costs and Clinical Outcomes in Breast Cancer Care' on Oct. 30.
Brief Summary: The goal of this study is to evaluate the efficacy and cost-effectiveness of the Living Well Program, a digital therapeutic application with telecoaching support, in breast cancer patients with moderate-to-severe anxiety. The main question the study aims to answer is: does digital cognitive-behavioral therapy-based interventions decrease the overall healthcare costs of patients with stage II to IV breast cancer?
The study has one group of participants who will use the Living Well app and telecoaching support. This...